Companies / Syndax Pharmaceuticals Inc / Activity
Activity — Syndax Pharmaceuticals Inc
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Wedbush Securities Inc 13F manager | New | Common stock | $212 | +9K | 9,054 0.01% of shares | low |
| Q1 2026 as of | Northwestern Mutual Wealth Management Co 13F manager | New | Common stock | $1.7K | +74 | 74 <0.01% of shares | low |
| Q1 2026 as of | Walleye Trading LLC 13F manager | New | Common stock | $9.7K | +416 | 416 <0.01% of shares | low |
| Q3 2025 as of | Farallon Capital Management LLC 13F manager | New | Common stock | $153.8K | +10K | 10,000 0.01% of shares | low |
| Q1 2026 as of | Magnetar Financial LLC 13F manager | New | Common stock | $252.1K | +11K | 10,791 0.01% of shares | low |
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $313.3K | +13K | 13,410 0.02% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common stock | $1.27M | +54K | 54,274 0.06% of shares | low |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | New | Common stock | $22.48M | +962K | 962,300 1.08% of shares | medium |
| Q1 2026 as of | Deerfield Management Company, L.P. 13F manager | New | Common stock | $88.30M | +3.8M | 3,779,900 4.23% of shares | high |